Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and Intermediates. It has a portfolio of molecules that cover multiple dosage forms including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The Company’s presence extends across therapies and includes anti-infectives, cardiovascular, pain management, central nervous system (CNS), gastrointestinal, respiratory, dermatology, orthopedics, nutritionals and urology. The Company has ground operations in 43 countries and manufacturing facilities spread across eight countries. Ranbaxy is a member of the Daiichi Sankyo Group, a Japan-based global pharmaceutical company.